Summary:A pilot clinical trial led by NYU Langone Health psychiatrists and biomedical engineers reveals that non-invasive transcranial ultrasound stimulation directed at the globus pallidus interna safely reduces delusions in individuals with schizophrenia and schizoaffective disorder. A single 10-minute session produced a clear, statistically meaningful decrease in delusion severity that persisted for up to one week compared to sham treatment, without significant adverse effects.Key Facts:Non-Invasive Deep Circuit Modulation: Using MRI-guided transcranial ultrasound stimulation, researchers delivered focused acoustic energy to the globus pallidus interna, a deep basal ganglia hub linked...
Catholic nuns don't make a habit of participating in long-term studies on aging and dementia, but one notable exception has yielded critical insights...
Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a four-dimensional brain map that...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for...
We're all familiar with Pavlovian conditioning, in which a reward-anticipatory behavior follows a reward-predicting stimulus. Perhaps you experience it yourself when passing a...